3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
20
Vitamin D Deficiency
17
Prostatic Neoplasms
14
Neoplasms
9
Polycystic Ovary Syndrome
8
Colonic Neoplasms
8
Rectal Neoplasms
6
Colorectal Neoplasms
6
Myelodysplastic Syndromes
5
Osteoporosis
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Cardiovascular Diseases
4
Warts
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Brain Neoplasms
3
Adenomatous Polyps
3
Pathologic Processes
2
Pain
2
Obesity
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Musculoskeletal Diseases
2
Melanoma
2
Male Urogenital Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Interventions
Pioglitazone
4
Sitagliptin Phosphate
3
Resistance Training
3
Vildagliptin
2
Sulfonylurea Compounds
2
Nutritional Status
2
Metformin
2
Dipeptidyl-Peptidase IV Inhibitors
2
Blood Specimen Collection
2
voglibose
1
saxagliptin
1
repaglinide
1
miglitol
1
metahexamide
1
meglitinide
1
mazdutide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
alogliptin
1
Urine Specimen Collection
1
Troglitazone
1
Tolbutamide
1
Tolazamide
1
Thiazolidinediones
1
Surveys and Questionnaires
1
Sodium-Glucose Transporter 2 Inhibitors
1
Rosiglitazone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Diabetes Mellitus, Type 2
×
Cholecalciferol
×
Clear all
NCT01463813
2018-10-23
FIND
University of Eastern Finland
Phase NA
Completed
2,495 enrolled